Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
3
×
genentech
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
boston
cancer
cancer immunotherapy
eli lilly
fda
investing
new york blog main
san francisco top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
avapritinib
bill cassidy
biogen
blueprint medicines
boulder/denver blog main
boulder/denver top stories
caelum biosciences
celgene
center for medicare and medicaid services
chuck grassley
clinical trials
What
drug
roche
acquire
agreed
alzheimer’s
approval
big
billion
bio
blueprint
broad
cancer
candidate
companies
confidence
currently
didn’t
different
fail
fda
foundation
gain
gene
genentech
increases
latest
marketing
medicine
medicines
momentum
morning
muscle
pact
panels
pay
pays
pharmaceutical
picked
plan
prescription
Language
unset
Current search:
genentech
×
roche
×
deals
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine